More than a dozen lawsuits have been filed on behalf of weight-loss drug users who claim that popular weight-loss medications such as Ozempic have caused a loss of vision.
Patients from New York and New Jersey have claimed that they suffered non-arteritic anterior ischemic optic neuropathy after taking drugs containing semaglutide — the active ingredient in Ozempic, Wegovy and Rybelsus. The condition is rare and includes a loss of blood flow to the optic nerve that causes sudden vision loss in one eye.
“People are just waking up and developing this [vision] condition,” Jason Goldstein, the lawyer representing the patients, told Newsday. “They wake and they totally can’t see. A lot of them lose their peripheral vision. They could lose total vision. I have one client who lost it in both eyes.”
The post Lawsuits are Piling up as Weight-Loss Drug Users Report Losing Their Sight: ‘I definitely wouldn’t have taken it’ appeared first on Easton Spectator.
Click this link for the original source of this article.
Author: Tom Appelby
This content is courtesy of, and owned and copyrighted by, https://www.eastonspectator.com and its author. This content is made available by use of the public RSS feed offered by the host site and is used for educational purposes only. If you are the author or represent the host site and would like this content removed now and in the future, please contact USSANews.com using the email address in the Contact page found in the website menu.
